Anti-Human CD37 Recombinant Antibody(Otlertuzumab)
-
产品编号
YR1329
-
别名
科研级 Otlertuzumab ( 奥乐妥珠单抗 ), Anti-CD37 Recombinant Antibody, Research Grade Otlertuzumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Otlertuzumab ( 奥乐妥珠单抗 ), Anti-CD37 Recombinant Antibody, Research Grade Otlertuzumab |
| Catalog Number | YR1329 |
| Molecular Name | Otlertuzumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | VH-V Kappa-CH2-CH3 |
| Formulation | PBS, pH7.5 |
| Background | Otlertuzumab (TRU- 016) is a humanized monoclonal antibody that targets CD37 designed for the treatment of cancer. This drug was developed by Emergent BioSolutions and has been in clinical trails for lymphoma and Chronic Lymphocytic Leukemia (CLL). |
| CAS Number | 1372645-37-8 |
| Application | ELISA, IP, FCM, FuncS, Neut, IF, ICC |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | CD37[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
